Physician

Frank Lacy, MD

According to 2025 Medicare claims, Frank Lacy, MD (NPI: 1457855835) practices micrographic dermatologic surgery in the Winston-Salem, NC market, with the plurality of this provider's patient population coming from Forsyth, NC. This provider's primary affiliated billing organization is DAVIE DERMATOLOGY, P.A. (NPI: 1922060649; TIN: 561986321) and primary practice location at 27006-7305.

Lacy's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 446 traditional Medicare patients, billed 1,990 HCPCS/CPT codes, and received $456,544 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 177 prescription claims across 124 beneficiaries totaling $3,730 in drug costs, led by Fluorouracil (Fluorouracil). Open Payments data shows 11 records totaling $867. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have fallen sharply in recent years, from $1,922 to $3,730. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$228K$457K2023 Medicare payment: $180,660 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $456,544 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023181693$180,660
20244461,990$456,544

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$415K$830K2018 Drug cost: $1,922 (USD; Tot_Drug_Cst)2019 Drug cost: $45,638 (USD; Tot_Drug_Cst)2020 Drug cost: $829,687 (USD; Tot_Drug_Cst)2021 Drug cost: $819,048 (USD; Tot_Drug_Cst)2022 Drug cost: $294,745 (USD; Tot_Drug_Cst)2023 Drug cost: $41,161 (USD; Tot_Drug_Cst)2024 Drug cost: $3,730 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20181435$1,922
2019117246$45,638
2020193440$829,687
2021199455$819,048
2022132301$294,745
202386122$41,161
2024124177$3,730

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks347463$420
17313Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks77105$388
17312Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks138213$303
88331Pathology examination of specimen during surgery, first tissue block80137$75
11102Biopsy of related skin growth, first growth8098$44

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
FluorouracilFluorouracil23658$1,623
Clobetasol PropionateClobetasol Propionate14359$779
MupirocinMupirocin28454$188
Doxycycline HyclateDoxycycline Hyclate20140$123
Ciprofloxacin HclCiprofloxacin Hcl1163$53

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.11$867E.R. Squibb & Sons, L.L.C.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Frank Lacy, MD?

Tedicare shows public-source Medicare data for Frank Lacy, MD (NPI 1457855835), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Frank Lacy, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Frank Lacy, MD?

Frank Lacy, MD is linked to DAVIE DERMATOLOGY, P.A. (billing NPI 1922060649) in the available physician profile data.

Does Frank Lacy, MD have Open Payments data?

Frank Lacy, MD has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.